Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Tata India Consumer Fund · Direct ✕HDFC Pharma and Healthcare Fund · Direct ✕

Growth of ₹10,000

Basics

Tata India Consumer FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseTataHDFC
NAV₹56.7149₹23.6750
NAV date20 Nov 202620 Nov 2026
History10.9 years3.1 years
Expense ratio0.9%1.1%
Stars★★★★★★★★★★
Growth Score53.5094.50

Returns

Tata India Consumer FundHDFC Pharma and Healthcare Fund
1 month+6.99%+12.97%
3 months+0.07%+7.13%
6 months+10.73%+17.84%
YTD+7.96%+33.73%
1 year+5.57%+32.20%
3 years (CAGR)+14.03%+30.70%
5 years (CAGR)+13.69%—
10 years (CAGR)+18.53%—
Since launch+17.21%+31.83%

Risk

Tata India Consumer FundHDFC Pharma and Healthcare Fund
Volatility17.7%15.8%
Downside volatility11.6%8.5%
Sharpe0.431.53
Sortino0.652.86
Calmar0.682.06
Return / risk0.801.95
Deepest fall−32.46%−14.91%
Days to recover235126
Below its high−0.72%+0.00%

Against benchmark

Tata India Consumer FundHDFC Pharma and Healthcare Fund
Alpha+1.92%+7.54%
Beta0.910.97
R²81.9%85.0%
Up capture89.8%108.9%
Down capture76.6%71.0%
Tracking error7.7%6.1%
Information ratio0.171.17
Treynor0.070.24

Consistency

Tata India Consumer FundHDFC Pharma and Healthcare Fund
Best 1-year+82.70%+67.01%
Middle 1-year+14.11%+23.25%
Worst 1-year−23.44%+1.71%
1-year periods with a loss13.7%0.0%
Middle 3-year+18.59%+30.22%
Positive months61.1%72.2%
Best day+4.72%+3.18%
Worst day−3.52%−3.61%
Worst 5% day−1.51%−1.51%
Positive days54.3%58.3%
NAVs a year247247

SIP of ₹10,000 a month

Tata India Consumer FundHDFC Pharma and Healthcare Fund
5-year XIRR+14.70%—
5-year value₹8,73,478—
3-year XIRR+10.51%+27.71%
1-year XIRR+17.07%+41.37%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth